Becton, Dickinson and Co. | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
Abbott USD 50.83B 1.76B 2025-06
Agilent USD 6.14B 109M 2025-04
Align Technology USD 3.79B 57.74M 2025-03
Avanos Medical USD 776.3M 63.1M 2025-06
Baxter International USD 7.05B 90M 2025-03
Becton, Dickinson and Co. USD 25.47B 231M 2025-06
Bio-Rad Laboratories USD 7.13B 449.3M 2025-06
Boston Scientific USD 22.21B 443M 2025-03
Cooper Companies USD 8.29B 160.6M 2025-04
Danaher USD 52.33B 1.48B 2025-06
Dentsply International USD 1.96B 50M 2025-06
Dexcom USD 2.57B 306.5M 2025-06
Edwards Lifesciences USD 10.19B 193.2M 2025-03
Exact Sciences USD 2.47B 72.51M 2025-06
Globus Medical USD 4.3B 207.61M 2025-06
Hologic USD 4.84B 223.8M 2025-06
Insulet USD 1.46B 132.2M 2025-06
Integra LifeSciences USD 1.04B 485.48M 2025-06
Intuitive Surgical USD 17.95B 745.4M 2025-06
J&J USD 78.11B 6.62B 2025-03
Masimo USD 1.04B 96.4M 2025-06
Medtronic USD 48.02B 1.36B 2025-04
Solventum Corp 3.64B 383M 2025-06
Stryker USD 21.19B 261M 2025-06
Tandem Diabetes Care USD 133.28M 22.01M 2025-06
Teleflex USD 4.24B 147.7M 2025-06
Terumo JPY 1.37T 536M 2025-06
Thermo Fisher Scientific USD 49.36B 227M 2025-03
Zimmer Biomet Holdings USD 12.53B 130.5M 2025-06


Becton, Dickinson and Co. رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.